Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 3
Submit an article Journal homepage
2,137
Views
4
CrossRef citations to date
0
Altmetric
Short Report

Safety of a quadrivalent influenza vaccine in Vietnamese healthy subjects aged 6 months and older

Vu Dinh Thiema Center for Clinical Trials, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, VietnamView further author information
,
Anne-Laure Chabanonb Sanofi Pasteur, Global Pharmacovigilance, Campus Sanofi Lyon, Lyon, FranceView further author information
,
Marion Fournierc Sanofi Pasteur, Medical Operations, Campus Sanofi Lyon, Lyon, FranceCorrespondence[email protected]
View further author information
,
Nathalie Lavisc Sanofi Pasteur, Medical Operations, Campus Sanofi Lyon, Lyon, FranceView further author information
,
Nguyen Dang Quanga Center for Clinical Trials, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, VietnamView further author information
,
Vu Hai Haa Center for Clinical Trials, National Institute of Hygiene and Epidemiology (NIHE), Hanoi, VietnamView further author information
&
Melvin Sanicasd Sanofi Pasteur Medical Asia and JPAC, Sanofi-Aventis (Singapore) Pte. Ltd, Singapore, SingaporeView further author information
 show all
Pages 690-693 | Received 10 Apr 2020, Accepted 08 Jul 2020, Published online: 12 Aug 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Tia Aoun, Ray Borrow & Peter D. Arkwright. (2023) Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of age. Expert Review of Vaccines 22:1, pages 226-242.
Read now
Xiaoyuan Huang, Ting Fan, Li Li, Xuanxuan Nian, Jiayou Zhang, Xuefen Gao, Wei Zhao, Wei Chen, Zhaoqing Zhang, Zhihao Yao, Xixin Han, Jinrong Shi, Ying Wang, Haihe Bian, Nianmin Shi, Xinguo Li, Kai Duan, Guohua Li & Xiaoming Yang. (2022) Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial. Human Vaccines & Immunotherapeutics 18:5.
Read now

Articles from other publishers (2)

Sunho Choe, Oxana Talanova, Sooyoun Shin, Olga Syrkina & Marion Fournier. (2023) Post-Marketing Safety Surveillance of Quadrivalent Influenza Vaccine (VaxigripTetra) in Children Aged 6 to 35 Months in South Korea. Infectious Diseases and Therapy 12:6, pages 1715-1723.
Crossref
Sookyung Lim, Xiaoling Li, Olga Syrkina & Marion Fournier. (2022) Post-marketing Surveillance of a Quadrivalent Influenza Vaccine (Vaxigrip Tetra) in South Korea. Infectious Diseases and Therapy 11:5, pages 2035-2043.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.